The dopamine D4 receptor:: one decade of research

被引:344
|
作者
Oak, JN
Oldenhof, J
Van Tol, HHM
机构
[1] Ctr Addict & Mental Hlth, Mol Neurobiol Lab, Clarke Div, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada
[3] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada
[4] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
关键词
dopamine D-4 receptor; G protein-coupled receptor; structure; pharmacology; signaling; physiology; genetics;
D O I
10.1016/S0014-2999(00)00562-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dopamine is an important neurotransmitter involved in motor control, endocrine function, reward, cognition and emotion. Dopamine receptors belong to the superfamily of G protein-coupled receptors and play a crucial role in mediating the diverse effects of dopamine in the central nervous system (CNS). The dopaminergic system is implicated in disorders such as Parkinson's disease and addiction, and is the major target for antipsychotic medication in the treatment of schizophrenia. Molecular cloning studies a decade ago revealed the existence of five different dopamine receptor subtypes in mammalian species. While the presence of the abundantly expressed dopamine D-1 and D-2 receptors was predicted from biochemical and pharmacological work, the cloning of the less abundant dopamine D-3, D-4 and D-5 receptors was not anticipated. The identification of these novel dopamine receptor family members posed a challenge with respect to determining their precise physiological roles and identifying their potential as therapeutic targets for dopamine-related disorders. This review is focused on the accomplishments of one decade of research on the dopamine D-4 receptor. New insights into the biochemistry of the dopamine D-4 receptor include the discovery that this G protein-coupled receptor can directly interact with SH3 domains. At the physiological level, converging evidence from transgenic mouse work and human genetic studies suggests that this receptor has a role in exploratory behavior and as a genetic susceptibility factor for attention deficit hyperactivity disorder. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:303 / 327
页数:25
相关论文
共 50 条
  • [21] The dopamine D4 receptor: biochemical and signalling properties
    Rondou, Pieter
    Haegeman, Guy
    Van Craenenbroeck, Kathleen
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (12) : 1971 - 1986
  • [22] Dopamine D4 Receptor Gene: Novelty or Nonsense?
    Andrew D Paterson
    Glen A Sunohara
    James L Kennedy
    [J]. Neuropsychopharmacology, 1999, 21 : 3 - 16
  • [23] A pharmacophore model for dopamine D4 receptor antagonists
    Boström, J
    Gundertofte, K
    Liljefors, T
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2000, 14 (08) : 769 - 786
  • [24] Role of Dimerization in Dopamine D4 Receptor Biogenesis
    Van Craenenbroeck, Kathleen
    Borroto-Escuela, Dasiel O.
    Skieterska, Kamila
    Duchou, Jolien
    Romero-Fernandez, Wilber
    Fuxe, Kjell
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2014, 15 (07) : 659 - 665
  • [25] Dopamine D4 receptor gene and the -521C>T polymorphism of the upstream region of the dopamine D4 receptor gene in schizophrenia
    Lung, For-Wey
    Chen, Nathan
    Shu, Bih-Ching
    [J]. PSYCHIATRIC GENETICS, 2006, 16 (04) : 139 - 143
  • [26] D2 and D4 dopamine receptor polymorphisms and personality
    Noble, EP
    Ozkaragoz, TZ
    Ritchie, TL
    Zhang, XX
    Belin, TR
    Sparkes, RS
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 81 (03): : 257 - 267
  • [27] Synthesis and receptor binding assay of indolin-2-one derivatives as dopamine D4 receptor ligands
    Li Gu-Cai
    Zhang Bian-Ling
    Xia Jiao-Yun
    Fang Zheng-Jun
    [J]. PHARMAZIE, 2015, 70 (08): : 511 - 514
  • [28] The dopamine D4 receptor VNTR in Polish schizophrenia patients
    Sanak, M
    Zelek-Molik, A
    Nalepa, I
    Wegrzyn, J
    Wciorka, J
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 73 (01) : 129 - 131
  • [29] Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs
    Cohen, BM
    Ennulat, DJ
    Centorrino, F
    Matthysse, S
    Konieczna, H
    Chu, HM
    Cherkerzian, S
    [J]. PSYCHOPHARMACOLOGY, 1999, 141 (01) : 6 - 10
  • [30] Recent advances in the molecular pharmacology of the dopamine D4 receptor
    Schetz, JA
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 81 : 33 - 33